Kexing Biopharm Introduces Eribulin Mesylate Injection, Expanding Its Overseas Product Portfolio
![Kexing Biopharm's Breast Cancer Medication Collaboration](https://wellnessnews24.com/wp-content/uploads/2024/01/pexels-cottonbro-studio-3952241-720x530.jpg)
2 min read
On the morning of January 3, Kexing Biopharm signed an international commercialization cooperation agreement on Eribulin Mesylate Injection, securing...